Journals / Turkish Neurosurgery / 2016 / Cilt: 26 - Sayı: 5

Evaluation of Aggressive Behavior and Invasive Features of Pituitary Adenomas Using Radiological, Surgical, Clinical and Histopathological Markers

Pages
671–677
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Fibrotic tumor structure, the surgical technique, the type of hormone, and cavernous sinus invasion affect the ability to perform a total resection and the overall prognosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: Total surgical resection of pituitary macroadenomas is difficult due to the location of the adenoma and the propensity to invade surrounding tissues.
📊
Key Findings & Data:RESULTS: We observed that the patients with macroadenomas in our study most frequently presented during their 5th decade.
💡
Conclusion & Impact:Fibrotic tumor structure, the surgical technique, the type of hormone, and cavernous sinus invasion affect the ability to perform a total resection and the overall prognosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AIM: Total surgical resection of pituitary macroadenomas is difficult due to the location of the adenoma and the propensity to invade surrounding tissues. The purpose of this study was to evaluate the risk factors for invasive and aggressive pituitary macroadenomas using radiological, hormonal, clinical, and immunohistochemical markers. MATERIAL and METhODS: Seventy cases of pituitary macroadenoma were examined. Age, gender, symptoms, the presence of fibrosis within the adenoma, hormonal levels, radiological findings, pathological results and immunohistochemical staining of the patients were evaluated using statistical methods. RESULTS: We observed that the patients with macroadenomas in our study most frequently presented during their 5th decade. The most frequent pituitary adenomas were non-functional, GH-secreting and PRL-secreting macroadenomas. The most frequent complaint was vision loss, headache and acral growth. Based on Magnetic Resonance Imaging (MRI) results, it was observed that the degree of invasion into surrounding tissues increased as the size of the macroadenoma increased. Macroadenomas that had invaded into the cavernous sinus invasion or that had a fibrotic tumor structure had a low probability of being resectable. There were no significant relationships between invasive behavior and p53, telomerase, ghrelin and CD46. CONCLUSION: It is not possible to identify only one factor that affects the prognosis of patients with pituitary macroadenomas. The contribution of the experience of surgeon to the treatment is surely beyond dispute. Fibrotic tumor structure, the surgical technique, the type of hormone, and cavernous sinus invasion affect the ability to perform a total resection and the overall prognosis.

🔖

Cite This Article

OZTURK, F., KURTSOY, A., BAYRAM, F., TUMTURK, A., KUCUK, A., TUCER, B., DURAK, A. C., DIRI, H., ORAL, S. (2022). Evaluation of Aggressive Behavior and Invasive Features of Pituitary Adenomas Using Radiological, Surgical, Clinical and Histopathological Markers. Turkish Neurosurgery, Cilt: 26 - Sayı: 5, 671–677. https://ajindex.com/articles/616943

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Asa SL: Practical pituitary pathology: What does the pathologist need to know? Arch Pathol Lab Med 132:1231- 1240, 2008 2. Beckers A, Aaltonen LA, Daly AF, Karhu A: Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 34:239- 277, 2013 3. Bilgin HM: Ghrelin; The renown hormone. Dicle Med J 33:268- 272, 2006 4. Blevins LS Jr, Verity DK, Allen G: Aggressive pituitary tumors. Oncology-NY 12:1307-1312, 1998 5. Ceylan S, Anık I, Koc K: A new endoscopic surgical classification and invasion criteria for pituitary adenomas involving the cavernous sinus. Turk Neurosurg 21:330-339, 2011 6. Cuny T, Pertuit M, Sahnoun-Fathallah M, Daly AF, Occhi G, Odou MF, Tabarin A, Nunes ML, Delemer B, Rohmer V, Desailloud R, Kerlan V, Chabre O, Sadoul JL, Cogne M, Caron P, Cortet C, Lienhardt-Roussie A, Raingeard I, Guedj AM, Brue T, Beckers A, Weryha G, Enjalbert A, Barlier A: Genetic analysis in young patients with sporadic pituitary macroadenomas: Beside AIP don't forget MEN1 genetic analysis. Eur J Endocrinol 168:533-541, 2013 7. Fahlbusch R, Buchfelder M, Nomikos P: Management options in the treatment of invasive pituitary tumors. In: Eisenberg MB, Al-Mefty O (eds). The Cavernous Sinus: A Comprehensive Text. Philadelphia: Lippincott Williams and Wilkins, 2000:291- 295 8. Farooq K, Rashid A, Malik TG: Pituitary macroadenomas: Demographic, visual and neuro-radiological patterns. Professional Med J 17: 623-627, 2010 9. Frank G, Pasquini E: Endoscopic endonasal cavernous sinus surgery, with special reference to pituitary adenomas. Front Horm Res 34:64-82,2006 10. Gejman R, Swearingen B, Hedly-Whyte T: Role of Ki- 67 proliferation index and p53 expression in predicting progression of pituitary adenomas. Hum Pathol 39:758-766, 2008 11. Horvath E, Scheithauer BW, Kovacs K, Lloyd RV: Hypothalamus and pituitary. In: Graham DI, Lantos PL (eds). Greeenfield's Neuropathology, 7th ed. London: Edward Arnold, 2002:983-1062 12. Jia W, Lu R, Jia G, Ni M, Xu Z: Expression of pituitary tumor transforming gene (PTTG) in human pituitary macroadenomas. Tumor Biol 34:1559-1567, 2013 13. Karabaglı H, Karabaglı P: Expression of p53 protein in the clinical behavior of invasive pituitary adenomas. Türk Nöroşir Derg 18:42-47, 2008 14. Kim K, Arai K, Sanno K, Osamura Y, Teramoto A, Scibasaki T: Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human